LATEST PRESS RELEASES


Notice: Function WP_Object_Cache::add was called incorrectly. Cache key must not be an empty string. Please see Debugging in WordPress for more information. (This message was added in version 6.1.0.) in /var/www/vhosts/shroominvestor.com/httpdocs/web/wp/wp-includes/functions.php on line 6031
109 views1 min read

Silo Pharma Inc. Receives One Million Dollars in Up Front Licensing Deal for its Psilocybin Cancer Therapeutic Applications in a Combination of Cash and Equities

Silo Pharma
Englewood Cliffs, NJ, Jan. 06, 2021 -- Silo Pharma, Inc. (OTCQB: SILO) a developmental stage biopharmaceutical company focused on the use of psilocybin as a therapeutic, today announced that it has entered into an agreement to license technology covered by provisional patent applications filed by Silo Pharma with the United States Patent ... Read More...
1076 views6 min read

Numinus Signs Lab Services Agreement with Optimi Health to Advance Research and Development of Psychedelic Products

Numinus Wellness
The agreement will focus on developing safe, effective, all-natural products for the emerging psychedelic industry  VANCOUVER, BC, Jan. 6, 2021 - Numinus Wellness Inc. ("Numinus") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing and supporting the safe, evidence-based, accessible use of psychede... Read More...
63 views7 min read

Mind Cure Announces Build-Out of Digital Therapeutics, iSTRYM: A Technology Platform for Mental Wellness Optimization & Psychedelic Research

Mind Cure Health
Mind Cure's iSTRYM (pronounced eye-stream) has been designed to warehouse the largest collection of psychedelic research and ongoing mental optimization data. With machine learning deployed, iSTRYM will provide greater speed to Mind Cure's research team, richer data to health professionals and clients, as well as a hub of protocol and pro... Read More...
72 views2 min read

Codebase Announces Financing

Cypher Metaverse
VANCOUVER, BC / ACCESSWIRE / January 5, 2021 / Codebase Ventures Inc. ("Codebase") (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces that it is undertaking a non-brokered private placement of up to $2 million, consisting of up to 12,500,000 units at $0.16 per unit. Each unit consists of one common share and one warrant entitling the holder to su... Read More...
132 views1 min read

Atlas One Granted Digital Securities License

Empower Clinics
VANCOUVER, BC, Jan. 4, 2021 - Atlas One Digital Securities Inc. (Atlas One) is pleased to announce that it has been granted registration as an Exempt Market Dealer (EMD) under the Canadian Securities Administrators (CSA) Regulatory Sandbox in conjunction with the British Columbia Securities Commission's (BCSC) Fintech & Innovation Tea... Read More...
363 views7 min read

Psychedelic Wellness-Focused Company Delic Corp Announces Shep Gordon to Join Advisory Board

Delic Holdings
/NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN UNITED STATES/VANCOUVER, BC, Jan. 5, 2021 - Delic Corp. ("DELIC" or the "Company") (CSE: DELC), a psychedelic wellness-focused company, is pleased to welcome Shep Gordon to the advisory board. Shep Gordon is an American talent manager, Hollywood film agent, a... Read More...
1209 views4 min read

Mydecine Innovations Group Sponsors First Lab-Based Study of Established Microdosers at Macquarie University in Australia

Mydecine Innovations Group
DENVER, Jan. 05, 2021 -- Mydecine Innovations Group (CSE: MYCO) (OTC: MYCOF) (FSE: 0NFA) (“Mydecine” or the “Company”), an emerging biopharma and life sciences company committed to the research, development, and acceptance of alternative nature-sourced therapeutic medicine for mainstream use, announced that it is sponsoring a study titled... Read More...
1045 views4 min read

Entheon Biomedical Announces Investment and Business Arrangement with Heading Health LLC

Entheon Biomedical
Vancouver, British Columbia--(Newsfile Corp. - January 4, 2021) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company"), a biotechnology company focused on developing psychedelic medicines to treat addiction, is announcing a business arrangement with, and a strategic investment in, Heading Health, LLC ("Heading Hea... Read More...
596 views8 min read

Four Top Psychedelic Stock Picks for 2021

Mind Medicine (MindMed)
The Top Companies Addressing Mental Health CrisisATLANTA, Jan. 04, 2021 -- 2020 was a banner year for investors in psychedelic companies as investors in Mind Medicine (MindMed) Inc. (OTCQB: MMEDF), 20/20 Global, Inc. (OTC: TWGL), Compass Pathways (NASDAQ: CMPS), and Numinus Wellness Inc. (OTC: LKYSF) saw their money triple and even quadru... Read More...
M & A40 views6 min read

Empower Clinics Closes Agreement to Acquire Canadian Clinics, Announces Significant Discussions with Nationwide Rollout Partners and Proceeds From Exercise of Warrants Now Exceeding $6,900,000 to Conclude its Most Successful Year Ever

Empower Clinics
Acquisition Will Expand Company's North American Footprint And Strengthen Vertical Integration From Patients To Laboratory, Strengthening Testing and Bubble InitiativesVANCOUVER, BC / ACCESSWIRE / January 4, 2021 / Empower Clinics (CSE:CBDT)(OTC PINK:EPWCF)(FRA:8EC) (the "Company" or "Empower"), an integrated healthcare company serving pa... Read More...
894 views4 min read

Dr. John Fahy Joins Revive Therapeutics as Scientific and Clinical Advisor for COVID-19 FDA Phase 3 Study

Revive Therapeutics
TORONTO, Dec. 31, 2020 -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (CSE: RVV, USA: RVVTF), a specialty life sciences company focused on the research and development of therapeutics for medical needs and rare disorders, is pleased to announce the appointment of Dr. John Fahy, MD, MSc, as a Scientific and Clinical advisor to the... Read More...
627 views4 min read

BetterPlant Subsidiary NeonMind Closes Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

Better Plant Sciences
Vancouver, British Columbia--(Newsfile Corp. - December 31, 2020) - Better Plant Sciences Inc. (CSE: PLNT) (OTCQB: VEGGF) (FSE: YG3) ("Better Plant") is pleased to announce that its partially owned subsidiary NeonMind Biosciences Inc. ("NeonMind") has successfully completed the maximum offering for its initial public offering (the "IPO")... Read More...
130 views7 min read

Mind Cure Announces Retail Roll Out of Nootropics Lineup Across North America with Body Energy Club

Mind Cure Health
Mind Cure's nootropic products are set to launch across 17 locations within North America starting Feb, 2021.VANCOUVER, BC, Dec. 31, 2020 - Mind Cure Health Inc. (CSE: MCUR) (OTCQB: MCURF) (FRA: 6MH) ("Mind Cure" or the "Company") is pleased to announce that Mind Cure's three nootropic supplements, Focus, Energy, and Immunity, will be ava... Read More...
1020 views4 min read

NeonMind Announces Closing of Oversubscribed Initial Public Offering and Exercise in Full of the Agent’s Over-Allotment Option

NeonMind Biosciences
Vancouver, British Columbia--(Newsfile Corp. - December 30, 2020) - NeonMind Biosciences Inc. (CSE: NEON) ("NeonMind"), is pleased to announce that it has successfully completed the maximum offering for its initial public offering (the "IPO") of 46,000,000 units of NeonMind (the "Units") at a price to the public of $0.10 per Unit, includ... Read More...
899 views4 min read

Red Light Holland To Make Groundbreaking Investment in St. Vincent and the Grenadines’ Plant-Based Wellness and Psychedelics Industry

Red Light Holland
Red Light Holland's investment through the expected acquisition of Mera Life Sciences would enable global expansion and create a major scientific research and development division to explore plant-based remedies and treatment clinics in the CaribbeanToronto, Ontario--(Newsfile Corp. - December 30, 2020) - Red Light Holland Corp. (CSE: TRI... Read More...
103 views6 min read

PharmaTher Announces Application for OTCQB Listing

TORONTO, Dec. 30, 2020 -- Newscope Capital Corporation (CSE: PHRM) (OTC Pink: PHRRF) (the “Company”), who through its wholly owned subsidiary, PharmaTher Inc., is a specialty life sciences company focused on the research and development of psychedelic pharmaceuticals, is pleased to announce that it has submitted its application for uplist... Read More...
68 views3 min read

Pure Extracts Commences Study on Psilocybin Oral Tablets, Capsules and Nasal Gel

Pure Extracts Technologies
VANCOUVER, British Columbia, Dec. 30, 2020 -- Pure Extracts Technologies Corp. (CSE: PULL) (XFRA: A2QJAJ) (“Pure Extracts” or the “Company”), a plant-based extraction company, is pleased to announce that it is commencing a study on the formulation and manufacturing of psilocybin based active treatments for oral tablets, capsules and a nas... Read More...
201 views7 min read

Numinus Announces Closing of $17 Million Bought Deal Offering Including Full Exercise of Over-Allotment Option

Numinus Wellness
Proceeds add to recently executed warrants and options of $8.9 million /NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR DISSEMINATION IN THE UNITED STATES/VANCOUVER, BC, Dec. 29, 2020 - Numinus Wellness Inc. ("Numinus" or the "Company") (TSXV: NUMI), a company creating an ecosystem of health solutions centered around developing... Read More...
124 views4 min read

Mountain Valley MD Completes Strategic Sale of Subsidiary, Finalizing Quicksome™ License Agreement

Mountain Valley MD Holdings
VANCOUVER, BC, Dec. 29, 2020 - Mountain Valley MD Holdings Inc. (the "Company" or "MVMD") (CSE: MVMD) (FRA: 20MP) is pleased to announce that Mountain Valley MD Inc. ("Mountain Valley") has completed the first portion of a multi-prong strategic agreement with Circadian Wellness Corp. ("Circadian"), a privately held Ontario corporation tha... Read More...
142 views2 min read

Nova Mentis Expands Psychedelic Drug Pipeline

Novamind
VANCOUVER, BC, Dec. 29, 2020 - Nova Mentis Life Science Corp. (CSE: NOVA) (FSE: HN3Q) (OTCPK: LIBFF) ("NOVA") is pleased to announce that it has added two additional psychedelic compounds to its drug portfolio. NOVA has contracted with its U.S. partner to begin manufacturing the active pharmaceutical ingredients (API), baeocystin and aeru... Read More...
125 views1 min read

Canbud Distribution Develops CBD Patient Distribution Network to Leverage Federal Sales License

Canbud Distribution
Toronto, Ontario--(Newsfile Corp. - December 29, 2020) - Canbud Distribution Corp. (CSE: CBDX) (FSE: CD0) ("Canbud") is pleased to announce that it has signed an agreement with a cannabis clinic to develop a CBD patient distribution network.Robert Tjandra, COO of Canbud comments, "this initiative demonstrates the Company's continuing exec... Read More...
149 views3 min read

BetterLife Pharma Strengthens Board of Directors

BetterLife Pharma
VANCOUVER, Dec. 28, 2020 -- BetterLife Pharma Inc. (“BetterLife” or the “Company”) CSE: BETR / OTCQB: BETRF / FRA: NPAU) an emerging biotech company, is pleased to announce that it has added Mr. Sergei Stetsenko to its Board of Directors to prepare for its growth phase in psychedelic medicines. Mr. Stetsenko is a financier and venture cap... Read More...
1399 views3 min read

Entheon Biomedical Closes Private Placement

Entheon Biomedical
Vancouver, British Columbia--(Newsfile Corp. - December 25, 2020) - Entheon Biomedical Corp. (CSE: ENBI) (FSE: 1XU1) ("Entheon" or the "Company") announces that it has closed a non-brokered private placement financing for total gross proceeds of CAD $3,174,374.25 (the "Placement"). The majority of the Placement was subscribed for by strat... Read More...
M & A116 views5 min read

New Wave Completes Acquisition of Way of Will Inc.- A Leading Retailer of Aromatherapy Products Extracted from Natural Aromatic Plant Extracts and Essential Oils

New Wave Holdings
TORONTO, Dec. 24, 2020 - NEW WAVE HOLDINGS CORP. (the "Company" or "New Wave") (CSE: SPOR) (FWB: 0XM2) (OTC: TRMNF) an investment issuer that provides capital and support services, is pleased to announced that further to its press release dated December 21, 2020, it has completed the acquisition (the "Transaction"). of all of the issued a... Read More...
M & A434 views5 min read

Core One Labs Signs Definitive Agreement for Acquisition of Biosynthetic Psilocybin Research Firm Vocan Biotechnologies Inc.

Core One Labs
VANCOUVER, BC / ACCESSWIRE / December 24, 2020 / Core One Labs Inc. (CSE:COOL), (OTC:CLABF), (Frankfurt:LD62), (WKN:A14XHT) (the "Company") is pleased to announce that, further to its press release of October 7, 2020, it has entered into a definitive share purchase agreement (the "Purchase Agreement"), dated December 23, 2020, for the acq... Read More...
375 views1 min read

Think Research Corporation Announces Grant of Equity Compensation and Appointment of Chief Operating Officer

Novamind
TORONTO, Dec. 22, 2020 - Eastwood Capital Corp. (the "Acquiror") has today filed an early warning report (the "Early Warning Report") advising of its acquisition of an aggregate of 2,211,400 common shares (the "Shares") of Automotive Finco Corp. (the "Company") through a private transaction. The Shares were purchased at a price of $1.50 p... Read More...
1099 views3 min read

Red Light Holland Announces Exercise of Warrants for Gross Proceeds of Over $5 Million

Red Light Holland
Toronto, Ontario--(Newsfile Corp. - December 24, 2020) - Red Light Holland Corp. (CSE:TRIP) (FSE:4YX) (OTC Pink:TRUFF) ("Red Light Holland" or the "Company") is pleased to announce that over the course of the last two weeks the Company has received over $5 million in gross proceeds from the exercise of warrants and company stock options. ... Read More...
694 views5 min read

Graph Earned $84,483 in Q2

Graph Blockchain
Toronto, Ontario--(Newsfile Corp. - December 24, 2020) -  Graph Blockchain Inc. (CSE: GBLC) (the "Company" or "Graph") is pleased to announce record second quarter 2021 ("Q2") financial and operating results. All currency is in Canadian dollars, unless otherwise stated.The company's net income increased to $84,483 in Q2 compared to a loss... Read More...





Make smarter investment strategies
with in-depth news reports

Join our subscribers!